+454.2%
MRNA vs HTZ
-65.3%
+519.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HTZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -5.3% | +1.9% | -2.5% |
| 7D | -10.1% | -10.4% | +0.3% | -8.4% |
| 30D | +126.7% | -2.4% | +129.1% | +128.3% |
| 3M | +184.1% | -60.9% | +245.0% | +202.6% |
| 6M | +143.3% | -50.2% | +193.5% | +150.8% |
| YTD | +359.9% | -59.7% | +419.6% | +382.4% |
| 1Y | +454.2% | -66.0% | +520.2% | +503.3% |
| All | +454.2% | -65.3% | +519.5% | +503.3% |
Cumulative growth
Daily Returns
Daily percentage return beside HTZ.
Daily Out/Under-Performance
Portfolio return minus HTZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HTZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HTZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling